Description
INCORPORATION OF FAR CLAUSE 52.222-90 DEI 852.204-72 AND INCORPORATE VAAR 852.204-72, PERSONNEL VETTING AND CREDENTIALING (MARCH 2026),
Base award description: GERMLINE PGX MOLECULAR TESTING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-09-30+$0= $0
- Mod P000012026-07-08+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-09-30 | +$0 | $0 | GERMLINE PGX MOLECULAR TESTING |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-07-08 | +$0 | $0 | INCORPORATION OF FAR CLAUSE 52.222-90 DEI 852.204-72 AND INCORPORATE VAAR 852.204-72, PERSONNEL VETTING AND CR… |
Related awards · 7
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HV15NRPPNU25)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C10X25N0264 | SAC FREDERICK (36C10X) · Q301 · REFERENCE LABORATORY TESTING | $11,387,675 | FY2025 |
| 36C10X24N0226 | SAC FREDERICK (36C10X) · Q301 · REFERENCE LABORATORY TESTING | $344,429 | FY2024 |
Other recipients under Q301 from SAC FREDERICK (36C10X) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C10X25N0265 | FULGENT THERAPEUTICS LLC | SAC FREDERICK (36C10X) | $6,573,600 | FY2025 |
| 36C10X25F0038 | EXACT SCIENCES CORPORATION | SAC FREDERICK (36C10X) | $1,481,749 | FY2025 |
| 36C10X24D0028 | FULGENT THERAPEUTICS LLC | SAC FREDERICK (36C10X) | $0 | FY2024 |
| 36C10X24N0227 | FULGENT THERAPEUTICS LLC | SAC FREDERICK (36C10X) | $2,949,000 | FY2024 |
| 36C10X24F0099 | EXACT SCIENCES CORPORATION | SAC FREDERICK (36C10X) | $438,653 | FY2024 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36C10X24D0027_3600 · retrieved 2026-09-26.